Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 12, 2021

SELL
$189.29 - $209.69 $232,069 - $257,079
-1,226 Closed
0 $0
Q2 2021

Jul 13, 2021

BUY
$155.9 - $187.99 $191,133 - $230,475
1,226 New
1,226 $229,000
Q1 2021

Apr 15, 2021

SELL
$144.0 - $169.39 $561,312 - $660,282
-3,898 Closed
0 $0
Q4 2020

Jan 13, 2021

BUY
$157.07 - $174.35 $54,189 - $60,150
345 Added 9.71%
3,898 $638,000
Q3 2020

Oct 09, 2020

SELL
$137.1 - $165.37 $8,774 - $10,583
-64 Reduced 1.77%
3,553 $588,000
Q2 2020

Jul 08, 2020

BUY
$111.92 - $142.53 $404,814 - $515,531
3,617 New
3,617 $496,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Symphony Financial, Ltd. Co. Portfolio

Follow Symphony Financial, Ltd. Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Symphony Financial, Ltd. Co., based on Form 13F filings with the SEC.

News

Stay updated on Symphony Financial, Ltd. Co. with notifications on news.